Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and mo

od JAMA Editors' Summary

  • 2025-02-07 16:05:00Datum vydání
  • 09:51Délka